Production lines halted at 4 facilities over gluten-free violations
The General Food and Drug Authority announced the suspension of production lines at four facilities that violated the specific requirements for "gluten-free" products. This followed a field study covering 61 facilities, which showed that most adhered to the regulations, while violations were identified in some establishments, leading to the suspension of their production lines. The Authority urged all facilities to comply with relevant legislation and to obtain the necessary approvals before marketing "gluten-free" products. It also emphasized the importance of preventing cross-contamination during manufacturing to ensure the safety of consumers who rely on these products due to health conditions. The regulatory campaigns will continue to ensure compliance, and complaints can be submitted via the hotline.
Notice: This Is an AI-Generated Summary
Comments (0)